Correlation Between CRISPR Therapeutics and Comba Telecom

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Comba Telecom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Comba Telecom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Comba Telecom Systems, you can compare the effects of market volatilities on CRISPR Therapeutics and Comba Telecom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Comba Telecom. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Comba Telecom.

Diversification Opportunities for CRISPR Therapeutics and Comba Telecom

0.62

Correlation Coefficient

CRISPR Therapeutics  Comba Telecom

Poor diversification

The 3 months correlation between CRISPR and Comba is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Comba Telecom Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Comba Telecom Systems and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Comba Telecom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Comba Telecom Systems has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Comba Telecom go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Comba Telecom

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 1.5 times more return on investment than Comba Telecom. However, CRISPR Therapeutics is 1.5 times more volatile than Comba Telecom Systems. It trades about 0.13 of its potential returns per unit of risk. Comba Telecom Systems is currently generating about 0.13 per unit of risk. If you would invest  4,080  in CRISPR Therapeutics AG on April 20, 2025 and sell it today you would earn a total of  1,470  from holding CRISPR Therapeutics AG or generate 36.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Comba Telecom Systems

CRISPR Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CRISPR Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Comba Telecom Systems

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Comba Telecom Systems are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Comba Telecom unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CRISPR Therapeutics and Comba Telecom

The main advantage of trading using opposite CRISPR Therapeutics and Comba Telecom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Comba Telecom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Comba Telecom will offset losses from the drop in Comba Telecom's long position.

The idea behind CRISPR Therapeutics AG and Comba Telecom Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.